Bio-Mimetic Nanovectors for Advanced Targeting

An academic spin-off of the University of Salerno

CARMA NanoVectors is advancing bio-mimetic nanovectors for the targeted delivery of biologically active molecules, including proteins, mRNA, siRNA, amino acids, and peptides. The platform is designed to improve bioavailability, cellular uptake, and therapeutic efficacy across pharmaceutical, nutraceutical, cosmetic, and regenerative medicine applications.

Targeting System
Membrane Proteins
The Metrics
Architectural Precision
The Shell
Bio-Mimetic Lipid Bilayer
The Payload Core
Versatile Cargo Capacity
Polymeric Nanoparticles
Lipid Nanoparticles

From Conventional Nanocarriers to
Bio-Mimetic Nanovectors

CARMA NanoVectors was established to address the limitations of conventional Lipid or Biopolymer Nanoparticles through a proprietary biomimetic nanocarrier platform that seamlessly integrates natural transmembrane proteins into precisely engineered vectors. This innovative architecture provides superior biocompatibility, enhanced targeting capabilities, and exceptional versatility for the delivery of a wide range of bioactive payloads.

Modular Design

Bio-Mimetic Architecture

Enhanced Compatibility​

Precision Targeting

Anatomy of a Precision
Bio-Hybrid Vector

  • The Shell | Biomimetic lipid bilayer engineered for maximum biocompatibility or biopolymer nanocarrier loaded with peptides.
  • The Targeting System | Integrated trans-membrane proteins enabling cellular recognition.
  • Precision Metrics | 180–250 nm as a mean size with PDI< 0.1
  • The Payload Core | Proteins, nucleic acids, or bioactive molecules.

One Platform,
Multiple Applications

Bio-Enhanced Cosmetics

Bio-revitalizing hydrogels and advanced aesthetic solutions.

Advanced Nutraceuticals

Enhanced bioavailability of natural compounds.

Biomimetic Prototypes

Custom-engineered lipid nanovectors integrating membrane proteins for delivery of bioactive compounds.​

Polymeric Nanoparticles

Custom-engineered polymeric nanoparticles.

Why choose CARMA Nanovectors

We unite scientific excellence and innovation to engineer next-generation nanomedicine solutions.
Patented Technology

Patent PCT/IT2024/050152.

Validated Research

In-vitro validation and preclinical development activities.

University Spin-Off

Official spin-off of the University of Salerno.

End-to-End Expertise

Research, formulation, characterization, validation and licensing.

Scientific Validation & Research Network

CARMA collaborates with leading academic and clinical research groups to validate bio-hybrid nanovector technologies for advanced therapeutic applications.

Distribution & Strategic Partnerships

B2B Sales & Licensing
Technology licensing for pharma, biotech and CDMO companies.

Collaborative Technology Transfer
Joint development projects with public and private institutions.

Scientific Networking
Participation in international biotech and innovation ecosystems.​

The easiest way to succeed is to copy nature!
180-250 nm
Controlled vesicle size
PCT Patent
Protected IP Platform
3 Core Markets
Pharma, Cosmetics, Nutraceuticals
University Spin-Off
Research-driven innovation platform